,Rank,NCTId,Condition,BriefTitle,InterventionName
0,1,NCT02213705,SYSTEMIC SCLERODERMA|ALLOGENEIC MESENCHYMAL STEM CELLS|ADULT,Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells,INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
1,2,NCT01770613,ST Segment Elevation Myocardial Infarction (STEMI)|Allogeneic Mesenchymal Bone Marrow Cells,A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With ST Segment Elevation Myocardial Infarction (STEMI),Stem cells
2,3,NCT00953485,Sjogren's Syndrome|Mesenchymal Stem Cells,Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS),Allogeneic Mesenchymal Stem Cells (AlloMSC)
3,4,NCT03925324,Ischemic Heart Disease|Non-ischemic Cardiomyopathy,Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist Device,Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)|Placebo
4,5,NCT01771679,Chronic Effect of Ultraviolet Radiation on Photoaged Skin|Dermatologic Disorders,Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging,Allogeneic Mesenchymal Bone Marrow Cells
5,6,NCT03042572,Peripheral Arterial Disease|Cardiovascular Diseases|Vascular Diseases,Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs,Allogeneic Mesenchymal Stromal Cell|Placebo
6,7,NCT04776239,Diabetes Mellitus|Ischemic Heart Disease,Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD),100 million Allogeneic Mesenchymal Human Stem Cells|Placebo
7,8,NCT01378182,Wilson's Disease,Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis,allogeneic mesenchymal stem cell transplantation
8,9,NCT00555828,Myocardial Infarction,Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction,Allogeneic Mesenchymal Precursor Cells (MPCs)|Standard-of-care treatment with NOGA® mapping and staged injections.|Allogeneic Mesenchymal Precursor Cells (MPCs)|Standard-of-care treatment with NOGA® mapping and staged injections.|Allogeneic Mesenchymal Precursor Cells (MPCs)|Standard-of-care treatment with NOGA® mapping and staged injections.
9,10,NCT02032004,Chronic Heart Failure,Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.,Allogeneic Mesenchymal Precursor Cells (MPCs)|Sham Comparator
10,11,NCT02886884,"Diabetes Mellitus, Type 2",Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects,20 million Allogeneic Mesenchymal Human Stem Cells|100 million Allogeneic Mesenchymal Human Stem Cells
11,12,NCT04366271,COVID,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,Mesenchymal cells|Standard of care
12,13,NCT03874572,Xerostomia Due to Radiotherapy|Hyposalivation|Xerostomia|Oropharynx Cancer|Salivary Gland Diseases|Dry Mouth|Mesenchymal Stem Cells|Mesenchymal Stromal Cells|Stem Cells,Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth,Allogeneic adipose derived stem/stromal cells
13,14,NCT00962923,Systemic Sclerosis|Mesenchymal Stem Cells,Allogeneic Mesenchymal Stem Cells Transplantation for Systemic Sclerosis (SSc),Allogeneic Mesenchymal Stem Cells (AlloMSC)
14,15,NCT04626583,Mesenchymal Stromal Cells|Cornea|Safety|Corneal Defect,Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells,Allogeneic MSC
15,16,NCT01851070,Rheumatoid Arthritis,A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor,Allogeneic Mesenchymal Precursor Cells|Normal Saline
16,17,NCT04385056,Bradykinesia,Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia,MSCTC-0010
17,18,NCT01759212,Heart Failure|Ischemic Cardiomyopathy,Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.,Allogeneic stem cells implantation
18,19,NCT03239535,Critical Limb Ischemia,Allogeneic Mesenchymal Stem Cells for the Critical Limb Ischemia Therapy,Mesenchymal stem cells|Normal saline
19,20,NCT01453738,Osteoarthritis of Knee,Allogeneic Mesenchymal Stem Cells in Osteoarthritis,Ex- vivo cultured adult allogeneic MSCs|Plasmalyte-A
20,21,NCT02467387,Non-Ischemic Heart Failure,A Study to Assess the Effect of Intravenous Dose of (aMBMC) to Subjects With Non-ischemic Heart Failure,Allogeneic Mesenchymal Bone Marrow Cells (aMBMC)|Lactated Ringer's Solution
21,22,NCT02866721,Cystic Fibrosis,Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis,Mesenchymal Stem Cells
22,23,NCT02104440,Cytopenia,Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro,"Sequential infusion of allogeneic mesenchymal stem cells expanded ""in vitro"""
23,24,NCT05086939,Knee Osteoarthritis,Multicenter Clinical Trial Comparing Treatment With Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control With Hyaluronic Acid in Patients With Knee Osteoarthritis.,Autologous MSCs|Allogenic MSCs|Hyaluronic Acid
24,25,NCT02421484,Septic Shock,Cellular Immunotherapy for Septic Shock: A Phase I Trial,Allogeneic mesenchymal stromal cells
25,26,NCT02677350,Crohn's Disease|Fistulizing Crohn's Disease|Stem Cells,AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE),Allogeneic Bone Marrow derived Human Mesenchymal Stem Cells (hMSCs)
26,27,NCT04876326,"Multiple System Atrophy|Parkinsonism|Multiple System Atrophy, Parkinson Variant",Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy,Autologous Adipose Mesenchymal Stem Cell Implantation|Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation|Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation
27,28,NCT03522545,Treatment-resistant Bipolar Depression,Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression,Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs)|Placebo
28,29,NCT00749164,Graft-Versus-Host Disease,Allogeneic Mesenchymal Stem Cell for Graft-Versus-Host Disease Treatment,MSC transplantation
29,30,NCT02140528,Tibial Fracture,Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures,Mesenchymal stem cell injection|Placebo
30,31,NCT01448434,Osteoarthritis of Knee Joint,Allogeneic Mesenchymal Stem Cells for Osteoarthritis,Ex- vivo cultured adult allogeneic MSCs|Plasmalyte-A
31,32,NCT02150551,Inflammatory Bowel Diseases,Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease,Allogeneic bone marrow-derived mesenchymal stromal cells
32,33,NCT01297413,Ischemic Stroke,A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke,Allogeneic adult mesenchymal bone marrow stem cells
33,34,NCT03673748,Lupus Nephritis|Lupus Erythematosus,Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells,Mesenchymal stromal cells (MSC)|Placebo
34,35,NCT03967275,Bone Marrow Donor,Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells in Severe Ocular Chemical Burn,bone marrow harvest
35,36,NCT03562065,Lupus Erythematosus|Stem Cell Transplant,Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord,mesenchymal stem cells
36,37,NCT03509870,Diabetic Foot Ulcer,Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds,mesenchymal stromal cells
37,38,NCT02687646,Acute Graft Versus Host Disease,Clinical Trial With MSC for Graft Versus Host Disease Treatment,Adult Allogeneic Mesenchymal cells from adipose tissue.
38,39,NCT01849159,Pulmonary Emphysema,"Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema",Mesenchymal stem cells|Reference therapy: 400 mL of 0.9% NaCl solution
39,40,NCT00721045,Heart Failure,A Phase II Dose-escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure,Mesenchymal Precursor Cells (MPCs)|Mesenchymal Precursor Cells (MPCs)|Mesenchymal Precursor Cells (MPCs)|standard-of-care treatment with mock mapping and injection procedures.|standard-of-care treatment with mock mapping and injection procedures.|standard-of-care treatment with mock mapping and injection procedures.
40,41,NCT01484574,Critical Limb Ischemia|Buerger's Disease,A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease,Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells
41,42,NCT04780685,Covid19,A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19,hMSC
42,43,NCT02387151,Rejection|Graft Loss,Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients,mesenchymal stromal cells
43,44,NCT05286255,COVID-19 Pneumonia|Viral Pneumonia,Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias,Allogeneic Mesenchymal Stromal Cells
44,45,NCT04869761,"Chronic Kidney Diseases|Diabetes Mellitus, Type 2|Diabetes Mellitus, Type 1|Diabetes Mellitus|Diabetic Nephropathies",Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion|Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions
45,46,NCT02509156,Cardiomyopathy Due to Anthracyclines,Stem Cell Injection in Cancer Survivors,Allo-MSCs|Placebo
46,47,NCT04432545,Systemic Sclerosis Pulmonary|Pulmonary Hypertension|Pulmonary Fibrosis,Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement,Mesenchymal Stem Cells from Wharton ́s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ́s jelly
47,48,NCT04535856,Covid19|Corona Virus Infection|SAR,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,allogeneic mesenchymal stem cell|Placebo
48,49,NCT04357600,Liver Cirrhoses,Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B,Allogeneic Umbilical Cord Mesenchymal Stem Cell
49,50,NCT01591200,Alcoholic Liver Cirrhosis,Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis,Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells|Allogeneic Mesenchymal Stem Cells
50,51,NCT01946048,Ischemic Cardiomyopathy,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy,mesenchymal stem cells
51,52,NCT04466007,Limb Ischemia|Diabetic Foot,Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia,High dose allogeneic mesenchymal stromal cells|Low dose allogeneic mesenchymal stromal cells|Placebos
52,53,NCT01795950,Pulmonary Arterial Hypertension,Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH),PLX-PAD
53,54,NCT03602872,Knee Osteoarthritis,Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis,Human allogeneic mesenchymal bone marrow derived stem cells
54,55,NCT02619877,Diabetic Foot Ulcer,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers,ALLO-ASC-DFU|Standard therapy
55,56,NCT02619851,Burn Injury,A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects,ALLO-ASC-DFU|Conventional Therapy
56,57,NCT03056742,Critical Limb Ischemia Due to Buerger's Disease,A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease,Stempeucel(R)
57,58,NCT03406585,Type1 Diabetes Mellitus,Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes,ProTrans: Allogeneic transplantation with WJMSCs|Placebos
58,59,NCT04348461,COVID|Respiratory Distress Syndrome,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells
59,60,NCT04476901,Non-ischemic Dilated Cardiomyopathy,Transendocardial Injection of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy,allogeneic human mesenchymal stem cells (hMSCs)|Placebo
60,61,NCT02630836,Femoral Neck Fracture,Allogeneic Mesenchymal Stromal Cells in Elderly Patients With Hip Fracture,XCEL-MT-OSTEO-BETA|Surgical treatment
61,62,NCT04501354,Osteoporosis,Evaluation of Clinical and Bone Density Improvement After Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord on Osteoporosis Patients,Mesenchymal Stem Cell
62,63,NCT04590118,Ischemic Stroke,Allogeneic Mesenchymal Stem Cells for the Survivors of Ischemic Stroke Trial (ASSIST),it-hMSC|Placebo
63,64,NCT01781390,Acute Myocardial Infarction,Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction,Placebo|Mesenchymal Precursor Cells (MPC) 12.5 M|Mesenchymal Precursor Cells (MPC) 25 M
64,65,NCT04361942,COVID-19 Pneumonia,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),Mesenchymal Stromal Cells|Placebo
65,66,NCT02594839,Idiopathic Interstitial Pneumonia|Interstitial Lung Disease|Idiopathic Pulmonary Fibrosis,Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease,Bone marrow mesenchymal stem cells|Placebo
66,67,NCT05113342,Multiple Myeloma|Relapse Multiple Myeloma,Descartes-25 in Relapsed/Refractory Multiple Myeloma,Descartes-25
67,68,NCT02625246,Bronchiectasis,Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non-Cystic Fibrosis Bronchiectasis,hMSCs
68,69,NCT04348435,COVID-19,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",HB-adMSCs|Placebos
69,70,NCT03137199,Asthma,Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma,hMSCs
70,71,NCT04545307,Pulp Necroses|Apical Periodontitis,Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis,Allogenic transplant of BM-MSC in a root canal from patients with immature apexes and pulpar necrosis and apical periodontitis
71,72,NCT03171194,System; Lupus Erythematosus,Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus,Low Dose Mesenchymal Stem Cells (MSCs)
72,73,NCT02893306,Type 1 Diabetes Mellitus,MSC Administration for the Management of Type 1 Diabetic Patients,MSCs
73,74,NCT02633163,Systemic Lupus Erythematosus,Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE),Low Dose Mesenchymal Stem Cells (MSCs)|High Dose Mesenchymal Stem Cells (MSCs)|Placebo Infusion
74,75,NCT04654286,Brachial Plexus Neuropathies,Human Amniotic Membrane and Mesenchymal Stem Cells Composite,Nerve transfer procedure|Nerve transfer with HAM-AdMSC composite wrapping
75,76,NCT01753440,Coronary Artery Disease|Ischemic Cardiomyopathy,Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy,Intramyocardial implantation of of a novel mesenchymal precursor cell type (iMP).
76,77,NCT03973827,Type1diabetes,Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes,ProTrans
77,78,NCT02323789,Recessive Dystrophic Epidermolysis Bullosa,Mesenchymal Stromal Cells in Adults With Recessive Dystrophic Epidermolysis Bullosa,Mesenchymal stromal cells
78,79,NCT03079401,Hypoplastic Left Heart Syndrome|Atrioventricular Canal,Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle,MPC; rexlemestrocel-L
79,80,NCT03183804,Diabetic Foot Ulcer,A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial,ALLO-ASC-DFU|Standard therapy
80,81,NCT05061030,Type1diabetes,Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents,the ATMP Protrans
81,82,NCT05060107,"Osteoarthritis, Knee",Intra-articular Injection of MSC-derived Exosomes in Knee Osteoarthritis (ExoOA-1),Exosomes (sEVs)
82,83,NCT01392625,Non-ischemic Dilated Cardiomyopathy,PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study),Autologous hMSCs|Allogeneic hMSCs
83,84,NCT01843387,Diabetic Nephropathy|Type 2 Diabetes,Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy,Mesenchymal Precursor Cells (MPCs)|Mesenchymal Precursor Cells (MPCs)
84,85,NCT01087996,Stem Cell Transplantation,The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study),Auto-hMSCs|Allo-hMSCs
85,86,NCT03356821,Perinatal Arterial Ischemic Stroke|Neonatal Stroke,Perinatal Arterial Stroke Treated With Stromal Cells Intranasally,Mesenchymal Stem Cells
86,87,NCT01576328,Type 2 Diabetes,Safety Study of Mesenchymal Precursor Cells in Type 2 Diabetes,Mesenchymal Precursor Cells (MPCs)|Mesenchymal Precursor Cells (MPCs)|Mesenchymal Precursor Cells (MPCs)
87,88,NCT05344157,"Osteoarthritis, Knee",A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis,XSTEM-OA
88,89,NCT02579369,Dystrophic Epidermolysis Bullosa,Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa,Allogeneic mesenchymal stem cells|Polyurethene Film
89,90,NCT05333029,Graft Versus Host Disease,Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD,Allogeneic mesenchymal stromal cells (MSCs)|Extracorporeal photopheresis (ECP)
90,91,NCT04314687,Cerebral Palsy,Stem Cell and Conditioned Medium for Cerebral Palsy,Umbilical Cord Mesenchymal Stem Cells|Conditioned Medium|Standard Therapy
91,92,NCT04506073,Parkinson's Disease,Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for iPD,MSC+placebo|MSC|Placebo
92,93,NCT04366323,Sars-CoV2,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
93,94,NCT01222039,Graft Versus Host Disease|Chronic and Expanded Graft Versus Host Disease|Immune System Diseases,Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.,Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.|Conventional treatment plus intravenous infusion of allogenic mesenchymal stem cells from adipose tissue.
94,95,NCT02398604,Hypoplastic Left Heart Syndrome,Allogeneic hMSC Injection in Patients With Hypoplastic Left Heart Syndrome,Allo-hMSCs|Placebo
95,96,NCT02685098,Ischemia|Peripheral Arterial Disease|Peripheral Vascular Disease|Vascular Disease|Arterial Occlusive Disease|Arteriosclerosis|Atherosclerosis|Cardiovascular Disease|Pathologic Processes|Orthopedic Procedures|Amputation,A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation,Allogeneic bone marrow derived mesenchymal stem cells
96,97,NCT02192736,Asthma,Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma,Trophic factors from umbilical cord mesenchymal stem cells
97,98,NCT03211793,Systemic Sclerosis|Digital Ulcer,Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis,Mesenchymal stromal cells|Placebo
98,99,NCT02003131,Osteoarthritis of the Knee,Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis,Trophic factors from umbilical cord mesenchymal stem cells
99,100,NCT04918706,Pulmonary Emphysema|Mesenchymal Stromal Cells,Allogeneic MSC Treatment for Pulmonary Emphysema,Allogeneic MSC|Placebo
100,101,NCT03487731,Facetogenic Back Pain|Back Pain,Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain,Allogeneic Human Mesenchymal Stem Cells (hMSCs)|Placebo
101,102,NCT00549913,Degenerative Disc Disease|Spondylolisthesis|Spinal Stenosis,Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF),NeoFuse|posterolateral spinal fusion with instrumentation
102,103,NCT03589287,Knee Osteoarthritis,Allogeneic Bone Marrow MSC Therapy for Knee Osteoarthritis,Chondrochymal®
103,104,NCT00810212,Degenerative Disc Disease|Degenerative Spondylolisthesis|Spinal Stenosis,Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion,PLF with autograft|PLF with NeoFuse|PLF with NeoFuse|PLF with NeoFuse
104,105,NCT01540292,Crohn's Disease,Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders,Mesenchymal Stem Cells (MSC)
105,106,NCT03905824,Osteochondral Fracture of Talus,The Effectiveness of Adding Allogenic Stem Cells After Traditional Treatment of Osteochondral Lesions of the Talus,Allogenic stromal mesenchymal cells derived from the umbilical cord|Debridement and microfracture
106,107,NCT03186417,Rheumatoid Arthritis,Mesenchymal Stem Cells in Early Rheumatoid Arthritis,2 million hMSC/kg|4 million hMSC/kg|6 million hMSC/kg|placebo
107,108,NCT05520086,Chronic Conjunctivitis|Stevens-Johnson Syndrome|Lyell Syndrome|Pemphigoid,Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.,Single Dose|Double Dose
108,109,NCT05177003,Crohn Disease|Ano Fistula,Study of the 12-month Efficacy of Stem Cell Injection in Crohn's Disease With Complex Ano-perineal Fistula,
109,110,NCT00186914,Osteodysplasia,Stromal Therapy of Osteodysplasia After Allogeneic Bone Marrow Transplantation,Marrow stromal cell infusion
110,111,NCT05165017,Pitt Hopkins Syndrome,Safety & Efficacy of AlloRx SC® in PTHS Patients,AlloRx Stem Cells®|Placebo control
111,112,NCT05157958,Dystrophic Epidermolysis Bullosa,Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa,ALLO-ASC-SHEET|Vehicle Control
112,113,NCT04340609,Acute Myocardial Infarction,Stem Cell in Acute Myocardial Infarction,Mesenchymal Stem Cells
113,114,NCT04314661,"Osteoarthritis, Knee",Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis,Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome|Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome|Non Arthroscopy with Mesenchymal Stem Cells + Secretome + Secretome|Non Arthroscopy with Secretome + Mesenchymal Stem Cells + Secretome
114,115,NCT04326959,Keloid,"Implantation of Mesenchymal Stem Cell, Conditioned Medium, or Triamcinolone Acetonide for Keloid",Umbilical Cord-Mesenchymal Stem Cells and Conditioned Medium|Conditioned Medium|Triamcinolone Acetonide
115,116,NCT04315025,Retinitis Pigmentosa,Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa,Umbilical Cord Mesenchymal Stem Cell (UC-MSC)|Conditioned Medium (CM)
116,117,NCT02145923,Neutropenic Enterocolitis|Myeloablative Chemotherapy Induced Bone Marrow Aplasia,Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis,Peripheral blood stem cell mobilisation and collection|High-dose chemotherapy|Bone marrow derived allogeneic MMSCs infusion|Autologous peripheral blood stem cells infusion
117,118,NCT01290367,Degenerative Disc Disease,Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain,Single Dose MPCs Injection|Single injection of saline solution|Single injection of hyaluronic acid|Single Dose MPCs Injection
118,119,NCT01775774,Acute Respiratory Distress Syndrome,Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells
119,120,NCT01956903,Chronic Graft-Versus-Host Disease,Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.,Allogenic Mesenchymal Stem Cell
120,121,NCT01983709,Prostate Cancer,Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer,Allogeneic Human Mesenchymal Stem Cells
121,122,NCT02824653,Graft Versus Host Disease,Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD,Mesenchymal Stem Cells
122,123,NCT04073472,"Crohn's Disease|Fistula|Anal Fistula|Pouch, Ileal|Pouches, Ileoanal",Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's,mesenchymal stem cells (MSCs)
123,124,NCT02675556,Treatment Resistant Depression,Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression,Allo-hMSCs|Placebo
124,125,NCT05522569,"Acute Ischemic Stroke|Mesenchymal Stem Cells|Stroke, Acute|Stroke/Brain Attack|Stroke, Ischemic",Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND),Allogeneic human mesenchymal stem cells (Allo-hMSCs)
125,126,NCT02672267,Myocardial Infarction,A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction,Stem cells|Placebo
126,127,NCT03929120,Interstitial Lung Disease|Connective Tissue Diseases,Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD),Allogeneic Bone Marrow Derived Mesenchymal Stem Cells (BMD-MSCs)
127,128,NCT02731586,Edentulous Alveolar Ridge,Effect on Allogenic Mesenchymal Stem Cells on Osseointegration of Dental Implants,Allogenic Mesenchymal stem cells
128,129,NCT02097641,"Respiratory Distress Syndrome, Adult",Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START),Allogeneic Bone Marrow-Derived Human Mesenchymal Stromal Cells|Plasma-Lyte A
129,130,NCT04519671,Perianal Crohn Disease|Perianal Fistula|Crohn Disease,Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease,Mesenchymal Stem Cells|Placebo
130,131,NCT02611167,Parkinson's Disease,Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease,Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg)|Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg)
131,132,NCT02763423,"Ketoacidosis, Diabetic",Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis,umbilical cord mesenchymal stem cell
132,133,NCT04791878,Perianal Fistula Due to Crohn's Disease (Disorder),Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease,Mesenchymal stem cells
133,134,NCT01763086,"Stem Cell Transplantation, Hematopoietic|Mesenchymal Stem Cells|Poor Graft Function|Hematological Diseases",Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant,Mesenchymal stem cells
134,135,NCT02412735,Degenerative Disc Disease,Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain,Rexlemestrocel-L|Rexlemestrocel-L + HA Mixture|Placebo
135,136,NCT01856140,Lateral Epicondylitis,Treatment of Tendon Injury Using Mesenchymal Stem Cells,ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection
136,137,NCT04388761,Ischemia Reperfusion Injury,Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI),Allogeneic adipose derived mesenchymal stem cells
137,138,NCT01586312,"Osteoarthritis, Knee|Arthritis of Knee|Knee Osteoarthritis",Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells,Allogenic mesenchymal stromal cells injection|Hyaluronic Acid
138,139,NCT04519697,Rectovaginal Fistula|Crohn Disease|Crohn Disease of Vulva|Rectolabial; Fistula,Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease,Mesenchymal Stem Cells|Placebo
139,140,NCT01914887,Ulcerative Colitis,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis,Allogeneic adipose tissue-derived mesenchymal stem cells
140,141,NCT05039411,Perianal Fistula Due to Crohn's Disease|Fistula in Ano,Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease,Human umbilical cord mesenchymal stem cells (UC-MSCs)
141,142,NCT04382547,"COVID|Covid-19|Coronavirus|Pneumonia|Pneumonia, Viral|Pneumonia, Interstitial|Sars-CoV2",Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Standard treatment according to the Clinical protocols
142,143,NCT03265808,Major Depressive Disorder|Alcohol Use Disorder,Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.,allogeneic human mesenchymal stem cells (allo-hMSCs)|Placebo
143,144,NCT02857010,Acute on Chronic Hepatic Failure,Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure,Allogenic mesenchymal stem cells|Placebo
144,145,NCT04519684,Ileal Pouch|Crohn Disease,Study of Mesenchymal Stem Cells for the Treatment of Ileal Pouch Fistula's in Participants With Crohn's Disease,Mesenchymal stem cells|Placebo
145,146,NCT01860417,Degenerative Disc Disease|Intervertebral Disc Disease|Low Back Pain,Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV),Allogenic Mesenchymal Stromal Cells|Mepivacaine
146,147,NCT04520022,Recessive Dystrophic Epidermolysis Bullosa,Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB,Human Umbilical Cord Blood-derived Mesenchymal Stem Cells
147,148,NCT03795974,"Cerebral Palsy, Spastic",Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy,MNC|MSC|Control
148,149,NCT04615455,"Keratoconjunctivitis Sicca, in Sjogren's Syndrome",Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome,ASCs|Cryostor CS10
149,150,NCT05017298,Corona Virus Infection|Covid19,Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells,Allogeneic adipose-derived stem cells
150,151,NCT03878628,Dry Eye|Kerato Conjunctivitis Sicca|Aqueous Tear Deficiency,Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease,Adipose tissue-derived mesenchymal stem cells
151,152,NCT01322906,Liver Failure,Allogeneic Bone Marrow Mesenchymal Stem Cells Transplantation in Patients With Liver Failure Caused by Hepatitis B Virus (HBV),Group 1|Group 2|Group 3
152,153,NCT02065245,Frailty,AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery,Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)|Placebo|Penicillin/Streptomycin-Free Allogeneic Human Mesenchymal Stem Cells (allo-hMSCs)
153,154,NCT02298023,Rotator Cuff Tear,Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear),allogenic adipose stem cell injection|fibrin glue/normal saline injection|normal saline injection
154,155,NCT04318600,Lupus Nephritis|Mesenchymal Stem Cells,Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis,human amniotic mesenchymal stem cell
155,156,NCT02013700,Idiopathic Pulmonary Fibrosis (IPF),Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER),Allogeneic Adult Human Mesenchymal Stem Cells (hMSCs)|matched placebo
156,157,NCT02215811,"Acute Respiratory Distress Syndrome, Adult",Treatment of Severe Acute Respiratory Distress Syndrome With Allogeneic Bone Marrow-derived Mesenchymal Stromal Cells,Mesenchymal stromal cells
157,158,NCT05152290,Spinal Cord Injuries,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI,AlloRx
158,159,NCT05147675,Osteoarthritis|Spinal Arthritis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA,AlloRx
159,160,NCT02013674,Chronic Ischemic Left Ventricular Dysfunction|Myocardial Infarction,The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study),Allogeneic hMSCs
160,161,NCT05158127,Skin Ulcer,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Skin Ulcer,AlloRx
161,162,NCT05147701,Eye Diseases|Retinitis Pigmentosa|Glaucoma|Diabetic Retinopathy|Macular Degeneration|Traumatic Optic Neuropathy|Optic Atrophy,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases,AlloRx
162,163,NCT05018858,Lupus,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus,AlloRx
163,164,NCT05158933,Ovarian Failure,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure,AlloRx
164,165,NCT05158101,Stroke,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Stroke,AlloRx
165,166,NCT05003960,Autism,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism,AlloRx
166,167,NCT05147766,Congestive Heart Failure|Angina,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease,AlloRx
167,168,NCT05158439,Tourette Syndrome,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome,AlloRx
168,169,NCT05003908,Diabetes,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes,AlloRx
169,170,NCT05147688,Pulmonary Disease|Asthma|Chronic Obstructive Pulmonary Disease,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Pulmonary Diseases,AlloRx
170,171,NCT05018819,Cerebral Palsy,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CP,AlloRx
171,172,NCT05152394,Parkinson Disease,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Parkinson's Disease,AlloRx
172,173,NCT05003388,Multiple Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS,AlloRx
173,174,NCT05003934,Rheumatoid Arthritis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA,AlloRx
174,175,NCT05152381,Osteoporosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis,AlloRx
175,176,NCT05018832,Traumatic Brain Injury,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI,AlloRx
176,177,NCT05018767,Frailty,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty,AlloRx
177,178,NCT05018845,Chronic Kidney Diseases,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD,AlloRx
178,179,NCT05016804,Systemic Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis,AlloRx
179,180,NCT05003947,Inflammatory Bowel Diseases,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IBD,AlloRx
180,181,NCT05016817,Idiopathic Pulmonary Fibrosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF,AlloRx
181,182,NCT05003921,Amyotrophic Lateral Sclerosis,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS,AlloRx
182,183,NCT05158114,Testicular Injury|Oligospermia,Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia,AlloRx
183,184,NCT02641860,Osteoarthritis,Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis,Mesenchymal progenitor cells
184,185,NCT04208646,Knee Osteoarthritis,Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis,Mesenchymal progenitor cells|No mesenchymal progenitor cells
185,186,NCT02587715,"Multiple Sclerosis, Relapsing-Remitting",A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS,Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells|Liberation therapy
186,187,NCT02418325,"Multiple Sclerosis, Relapsing-Remitting",A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS,Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells|Liberation therapy
187,188,NCT04447833,"ARDS, Human|COVID",Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,Mesenchymal Stromal Stem Cells - KI-MSC-PL-205
188,189,NCT05042206,Chronic Kidney Disease Stage 3B|Chronic Kidney Disease stage4,Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease,Cellgram-CKD
189,190,NCT01678534,Ischemic Stroke,"Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial",Allogenic mesenchymal stem cells from adipose tissue|Placebo
190,191,NCT04184258,Systemic Lupus Erythematosus,Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells,Pooled mesenchymal stem cell|Standard treatment according to the Clinical protocols
191,192,NCT02855112,"Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]",Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients,Adipose derived mesenchymal stem cell
192,193,NCT02235844,Duchenne's Muscular Dystrophy,Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD),Umbilical Cord Mesenchymal Stem Cells
193,194,NCT05016011,"Osteoarthritis, Knee",Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury,Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)|Marrow cellution
194,195,NCT02384499,Fecal Incontinence,"Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study",ALLO-ASC injection|Placebo
195,196,NCT04336254,COVID-19,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Intravenous saline injection (Placebo)
196,197,NCT02833792,Alzheimer Dementia,Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease,Human Mesenchymal Stem Cells and Lactated Riunger's Solution|Placebo
197,198,NCT00447460,Graft-vs-Host Disease (GVHD),Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell,Mesenchymal stem cell (MSC)
198,199,NCT04543994,Ulcerative Colitis,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC),Remestemcel-L|Remestemcel-L|Placebo
199,200,NCT01649687,Cerebellar Ataxia,Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells,Allogeneic adult adipose-derived mesenchymal stem cells
200,201,NCT02338375,Osteochondral Lesion of Talus,Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product,Cartistem
201,202,NCT01902082,ARDS,Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome,Mesenchymal stem cells|Placebo
202,203,NCT04548583,Crohn Colitis,Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis,Remestemcel-L|Remestemcel-L|Placebo
203,204,NCT05532943,Multiple Sclerosis,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Allogeneic umbilical cord mesenchymal stem cells|Control group
204,205,NCT05501418,COVID-19 Infection,Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19,Allogeneic umbilical cord mesenchymal stem cells|Controlled normal saline
205,206,NCT01144962,Crohn's Disease|Fistula,Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease,"Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.|Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection."
206,207,NCT02307435,Non Union Fracture|Metaphyseal Fibrous Defect,Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture,MSC
207,208,NCT03818854,"Respiratory Distress Syndrome, Adult",Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome,Human Mesenchymal Stromal Cells|Cell Reconstitution Media
208,209,NCT04280003,Ischemic Stroke|Adipose Tissue-derived Stem Cell|Functional Status,Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells in Ischemic Stroke,Alogenic adipose tissue-derived stem cells|Placebo solution
209,210,NCT04087889,Pancreatic Cancer,Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer,HB-adMSCs
210,211,NCT03265613,Mesenchymal Stromal Cells|Psoriasis|Drug Toxicity|Drug Effect,Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis,adipose-derived multipotent mesenchymal stem cells
211,212,NCT03800810,"Osteoarthritis, Knee",Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management,Hyaluronic Acid|Umbilical Cord Mesenchymal Stem Cell|Recombinant Human Somatropin
212,213,NCT00698191,Refractory Systemic Lupus Erythematosus,Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE),Allogeneic MSC (AlloMSC)
213,214,NCT03449082,Lateral Epicondylitis,Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC),High concentration of Allo-ASC|Low concentration of Allo-ASC|Fibrin glue|Normal saline
214,215,NCT03384433,Cerebrovascular Disorders,Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke,exosome
215,216,NCT05078385,Burns,Safety of Mesenchymal Stem Cell Extracellular Vesicles (BM-MSC-EVs) for the Treatment of Burn Wounds,AGLE-102
216,217,NCT01526850,Chronic Graft Versus Host Disease,Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease,Biological: mesenchymal stem cell|Cyclosporine and Glucocorticoid
217,218,NCT03865394,Diabetic Foot Ulcer,Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells,Application of allogeneic ADSC stem cells in fibrin gel|Standard care in diabetic foot ulcer
218,219,NCT01440309,Primary Biliary Cirrhosis,Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis,Biological: mesenchymal stem cell|ursodeoxycholic acid
219,220,NCT03184935,Myelodysplastic Syndromes,Research for Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-MDS) in the Treatment of Myelodysplastic Syndrome (MDS),Allogeneic umbilical cord mesenchymal stem cells|Decitabine
220,221,NCT02192749,Autism,Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism,Umbilical cord mesenchymal stem cells
221,222,NCT03180463,Osteonecrosis of Femoral Head,The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ONFH),Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|core decompression
222,223,NCT04909892,Covid19,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",COVI-MSC
223,224,NCT05152368,Peripheral Neuropathy|Trigeminal Neuralgia,Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy,AlloRx
224,225,NCT01552707,"Lumbar Spondylolisthesis Involving L4-L5, and/or|Degenerative Discopathy Involving L4-L5",Safety Study of Mesenchymal Stem Cells and Spinal Fusion,XCEL-MT-OSTEO-ALPHA|Standard treatment
225,226,NCT00504803,Hematological Malignancies,Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease,Mesenchymal stem cell infusion
226,227,NCT03186456,Cerebral Infarction,The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction,Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|Aspirin Tablet
227,228,NCT04889963,Adypose Mesenchimal Stem Cell|Ligament Rupture|Ligament Derived Conditined Medium,Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium,adypose mesenchymal conditioned medium and ligament derived conditioned medium
228,229,NCT02804945,Blood And Marrow Transplantation|Adult Respiratory Distress Syndrome,Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies,Mesenchymal Stem Cells (MSCs)
229,230,NCT05147779,Erectile Dysfunction|Peyronie's Disease|Interstitial Cystitis,"Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis",AlloRx
230,231,NCT02940418,Diabetes Mellitus Type 1,Use of Stem Cells in Diabetes Mellitus Type 1,Adipose mesenchymal cells with bone marrow mononuclear cells
231,232,NCT01092026,Allogeneic Stem Cell Transplantation,Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells,cord blood transplantation
232,233,NCT03180450,Heart Failure,The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF),Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)|conventional treatment
233,234,NCT03473301,Cerebral Palsy,A Study of UCB and MSCs in Children With CP: ACCeNT-CP,Infusion of allogeneic umbilical cord blood|Infusion of MSCs
234,235,NCT05491681,"ARDS, Human",AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial,intravenous delivery of allogeneic bone marrow-derived MSCs
235,236,NCT03176498,Cerebral Infarction,Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.,Allogeneic umbilical cord mesenchymal stem cell|Aspirin Enteric-coated Tablets & Atorvastatin Calcium
236,237,NCT05130983,Crohn Disease|IBD - Irritable Bowel Disease,"A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease",Bone Marrow MSC Derived Extracellular Vesicle Isolate
237,238,NCT04328714,Acute Leukemia|Myelodysplastic Syndromes,Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease,Interferon gamma (IFNγ)-primed human bone marrow-derived mesenchymal stromal cells
238,239,NCT02881476,Amyotrophic Lateral Sclerosis,Therapeutic Treatment of Amyotrophic Lateral Sclerosis,Biological: Cell-based therapy
239,240,NCT04056819,Acute Myocardial Infarction,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction,Allogeneic umbilical cord mesenchymal stem cells
240,241,NCT04992247,Covid19,"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 ""Long Haul"" Pulmonary Compromise",COVI-MSC|Placebo
241,242,NCT04905836,Covid19,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress,COVI-MSC|Placebo
242,243,NCT04909879,Acute Respiratory Distress Syndrome|Ards,Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome,COVI-MSC|Placebo
243,244,NCT05362786,Chronic Kidney Diseases,Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease,Allogeneic adipose-derived mesenchymal stem cells (MSC)|Allogeneic adipose-derived mesenchymal stem cells (MSC)
244,245,NCT04728698,Covid19|ARDS,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,COVI-MSC|Placebo
245,246,NCT02108132,Hemophilia,Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia,Cellular therapy|cellular therapy
246,247,NCT03113747,Second- or Third-degree Burns,Allogeneic ADSCs and Platelet-Poor Plasma Fibrin Hydrogel to Treat the Patients With Burn Wounds (ADSCs-BWs),ALLO-ASCs
247,248,NCT02230514,Atrophic Nonunion of Fracture,Mesenchymal Stromal Cells for the Treatment of Non-union Fractures of Long Bones,XCEL-MT-OSTEO-ALPHA|autologous iliac crest|Surgery
248,249,NCT04289194,Acute Respiratory Distress Syndrome,Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome,HCR040 (Phase 1)|Placebo (Phase 2)|HCR040 (Phase 2)
249,250,NCT03994666,Critical Limb Ischemia,Cell Therapy in Critical Limb Ischemia,allogeneic umbilical cord-derived mesenchymal stem cells|Placebo (NaCl)
250,251,NCT04785027,Traditional Chinese Medicine|Drug Effect|Drug Safety|Psoriasis|Mesenchymal Stromal Cells,Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis,PSORI-CM01 formula|Gu Ben Hua Yu formula|adipose-derived multipotent mesenchymal stem cells
251,252,NCT04341610,Respiratory Tract Diseases,ASC Therapy for Patients With Severe Respiratory COVID-19,Stem Cell Product
252,253,NCT04255147,Bronchopulmonary Dysplasia,Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia,Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells
253,254,NCT04236479,Congenital Heart Disease (CHD),Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP),BM-MSC
254,255,NCT02587572,Metabolic Disease|Endothelial Dysfunction,Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial,Peripheral Intravenous (IV) infusion of LMSCs
255,256,NCT00972660,Graft Versus Host Disease,Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease,Mesenchymal stem cell (MSC)|Prednisone and cyclosporine or primary therapies
256,257,NCT04714801,Lung Transplant Rejection,Adipose Derived Mesenchymal Cell Treatment in Lungtransplantation,adipose derived mesenchymal stromal cells|Saline
257,258,NCT05132972,Covid 19,Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients,Normoxic Allogenic UCMSC|Normal saline solution
258,259,NCT04433104,COPD,Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease,Umbilical Cord Mesenchymal Stem Cells transplantation|drug therapy according to Vietnamese MOHS procedure
259,260,NCT02336646,Critical Limb Ischemia,Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease,Allogenic MSC|Normal saline
260,261,NCT04467047,COVID-19|Sars-CoV2,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,Mesenchymal Stromal Cells infusion
261,262,NCT04392206,End Stage Renal Disease,AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses,Adipose Derived Mesenchymal Stem Cells
262,263,NCT04247945,Allogeneic Hematopoietic Stem Cell Transplantation,Co-transplantation of MSC in the Setting of Allo-HSCT,Cotransplant with MSCs
263,264,NCT03369275,Septic Shock|Sepsis|Pathologic Processes|Shock|Infection|Systemic Inflammatory Response Syndrome|Inflammation,Cellular Immunotherapy for Septic Shock,Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells|Placebo
264,265,NCT02083718,"Stem Cell Transplantation, Hematopoietic|Poor Graft Function|Hematological Diseases",Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function,PBSC|MSCs
265,266,NCT04602104,Acute Respiratory Distress Syndrome,A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDS,low dose hMSC-Exos|medium dose hMSC-Exos|high dose hMSC-Exos|Dosage 1of hMSC-Exos|Dosage 2 of hMSC-Exos|No hMSC-derived exosomes
266,267,NCT01091701,Stroke,Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke,Ex vivo cultured adult allogenic MSCs|Plasmalyte-A
267,268,NCT04461925,COVID-19 Pneumonia,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Antibiotics|Hormones|Anticoagulant Therapy|Оxygen therapy
268,269,NCT03389919,Mesenchymal Stem Cell Transplantation,Intraosseous Administration of Mesenchymal Stromal Cells for Patients With Graft Failure After Allo-HSCT,MSC administration (intraosseal)
269,270,NCT03609905,Ulcerative Colitis (UC),Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis,Adipose-cord mesenchymal stromal cells (A-MSCs)|Conventional drugs
270,271,NCT01297972,Aplastic Anemia,Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia,Intravenous bone marrow mesenchymal stem cells infusion
271,272,NCT03337243,Knee Osteoarthritis|Knee Pain Chronic|Joint Disease|Arthritis|Osteo Arthritis Knee|Musculoskeletal Disease,Effect of Implanting Allogenic Cytokines Derived From Human Amniotic Membrane (HAM) and Mesenchymal Stem Cells Derived From Human Umbilical Cord Wharton's Jelly (HUMCWJ) on Pain and Functioning of Knee Osteoarthritis,HAM and HUMCWJ Injections
272,273,NCT02408432,Cardiomyopathy|Heart Failure,Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines,Laboratory Biomarker Analysis|Standard of Care|Mesenchymal Stem Cell Transplantation
273,274,NCT04549285,Multisystem Inflammatory Syndrome in Children,Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome,Human Cord Tissue Mesenchymal Stromal Cells (hCT-MSCs)
274,275,NCT04869397,Covid19,Treatment of Respiratory Complications Associated With COVID-19 Using Umbilical Cord Mesenchymal Stromal Cells,Allogeneic Wharton's jelly-MSCs (WJ-MSC)|Placebo
275,276,NCT03326505,Multiple Sclerosis,Allogenic Mesenchymal Stem Cells And Physical Therapy for MS Treatment,Umbilical cord derived Mesenchymal Stem Cells|Supervised physical therapy
276,277,NCT04939337,Crohn's Disease,A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.,TH-SC01
277,278,NCT02846883,Abdominal Aortic Aneurysm,Safety and Efficacy of Allogeneic MSCs in Promoting T-regulatory Cells in Patients With Small Abdominal Aortic Aneurysms,MSCs|MSCs|Placebo
278,279,NCT01562002,Limbus Corneae Insufficiency Syndrome,Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome,Stem Cell with Amniotic Membrane Transplant
279,280,NCT03174587,Lupus Nephritis,Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis,allogenic bone marrow derived mesenchymal stem cells
280,281,NCT04670302,Supraspinatus Tear,Mesenchymal Stem Cells and Amniotic Membrane Composite for Supraspinatus Tendon Repair Augmentation,Tendon repair procedure|Tendon repair augmented with AAdMSC-HAM composite
281,282,NCT05176366,Ulcerative Colitis,Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis,ExoFlo
282,283,NCT05553132,Cartilage Defect,A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects,Autologous Chondrocytes in their Pericellular Matrix (Chondrons) Coimplanted with Allogeneic Adipose-Derived Mesenchymal Stromal Cells (AMSCs) in a Fibrin Glue Carrier
283,284,NCT04995081,Parkinson Disease,Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD),Biological/Vaccine: Allogeneic HB-adMSCs|Placebo
284,285,NCT02382874,Focal Segmental Glomerulosclerosis,Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis),Intravenous injection
285,286,NCT04362189,COVID-19,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,HB-adMSC|Placebo
286,287,NCT04939077,"Myocardial Ischemia|Ventricular Dysfunction, Left",Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC),Allogeneic Human Umbilical Cord Mesenchymal Stem Cells
287,288,NCT02328612,Sepsis,"Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers",Intravenous infusion of cells
288,289,NCT01605383,Avascular Necrosis of Femur Head,Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head,XCEL-MT-OSTEO-ALPHA|Standard treatment
289,290,NCT03860155,Acute-On-Chronic Liver Failure,Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure,allo-APZ2-ACLF
290,291,NCT04040348,Alzheimer Disease,Alzheimer's Disease Stem Cells Multiple Infusions,Approximately 100 million cells allogeneic hMSC
291,292,NCT00603330,Graft-versus-host Disease|Poor Graft Function|Low Donor T-cell Chimerism,Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function,Mesenchymal stem cells
292,293,NCT05464381,Epidermolysis Bullosa,"Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)",allo-APZ2-OTS|Placebo
293,294,NCT02241018,Acute Graft-versus-host Disease,MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD,CD25 monoclonal antibody|calcineurin inhibitors|MSCs
294,295,NCT03058068,Cystic Fibrosis,Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis,Allo-hMSCs|Placebo
295,296,NCT05521672,Stenosis; Bowel|Crohn Disease,Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease,Adipose derived allogenic mesenchymal stem cells (adAMSC)
296,297,NCT02829216,Abnormal Hematopoiesis|Allogenic Disease|Graft vs Host Disease,Graft-versus-host Disease Associated Myelosuppression,
297,298,NCT02585622,Diabetic Kidney Disease,NEPHSTROM for Diabetic Kidney Disease,Mesenchymal Stromal Cells|Placebo
298,299,NCT02563340,Kidney Transplantation,Effect of BM-MSCs on Chronic AMR After Kidney Transplantation,"BM-MSCs|Desensitization therapy (PP, IVIG, rituximab or Bortezomib)"
299,300,NCT02563366,Kidney Transplantation|Acute Kidney Tubular Necrosis,Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.,BM-MSCs|Saline
300,301,NCT01549665,Graft-Versus-Host Disease|GVHD|Allogeneic Hematopoietic Transplant|Disorder Related to Transplantation,Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease,Human umbilical cord blood-derived mesenchymal stem cells
301,302,NCT01589549,Acute GVH Disease,Mesenchymal Stromal Cells for Acute Graft Versus Host Disease,Mesenchymal stromal cell therapy
302,303,NCT02104713,Skin Burn Degree Second,Stem Cell Therapy to Improve Burn Wound Healing,Allogeneic (MSC's) Application to the Burn Wounds
303,304,NCT02709343,Chronic Lung Allograft Dysfunction (CLAD),Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction,Bone-marrow derived MSCs|Placebo
304,305,NCT04034316,Nephrotic Syndrome in Children|Steroid-Dependent Nephrotic Syndrome|Idiopathic Nephrotic Syndrome,Reduce Immunosuppression With Atmp in NS ChildrEn,Cord-blood mesenchymal stromal cells
305,306,NCT02290041,Discordant Immunological Response in HIV Infected Subjects,Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response,Infusion of MSC|Infusion of placebo
306,307,NCT03798353,Myocardial Infarction,Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue,PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.|Surgery by sternotomy
307,308,NCT01741857,Systemic Lupus Erythematosus,Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus,human umbilical cord derived MSC transplantation for SLE
308,309,NCT04971161,Skin Ulcer Venous Stasis Chronic,Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb),allo-APZ2-CVU|Placebo
309,310,NCT02240992,"Stem Cell Transplantation, Hematopoietic|Poor Graft Function|Delayed Platelet Engraftment|Hematological Diseases",MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment,PBSC|MSCs
310,311,NCT04758533,"Diffuse Intrinsic Pontine Glioma|Medulloblastoma, Childhood, Recurrent",Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy,AloCELYVIR
311,312,NCT00883727,Myocardial Infarction,Ex Vivo Cultured Bone Marrow Derived Allogenic MSCs in AMI,Stem cell|Plasmalyte A
312,313,NCT04410731,Facet-Mediated Low Back Pain,Allogeneic BM-MSCs in Patients With Lumbar Facet Arthropathy,Single bilateral intra-articular injection of allogeneic BM-MSCs for lumbar facet joint arthropathy
313,314,NCT04623606,Osteogenesis Imperfecta,Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones,BOOST cells
314,315,NCT03706482,Osteogenesis Imperfecta,Boost Brittle Bones Before Birth,BOOST cells
315,316,NCT01922908,Ischemic Stroke,Mesenchymal Stromal Cells for Ischemic Stroke,MSC Infusion|Placebo Comparator
316,317,NCT04388982,Alzheimer Disease,the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease,low dosage MSCs-Exos administrated for nasal drip|mild dosage MSCs-Exos administrated for nasal drip|high dosage MSCs-Exos administrated for nasal drip
317,318,NCT04527224,Covid19 Pneumonia,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,AstroStem-V
318,319,NCT00314483,Graft vs Host Disease,Evaluation of the Role of Mesenchymal Stem Cells in the Treatment of Graft Versus Host Disease,Mesenchymal Stem Cell Infusion
319,320,NCT04835883,Systemic Lupus Erythematosus,Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients,CS20AT04 (allogenic bone marrow derived mesenchymal stem cell)
320,321,NCT04497805,Diabetic Foot Ulcer,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers,ALLO-ASC-SHEET
321,322,NCT04494386,Covid19|Corona Virus Infection|SARS-CoV Infection|ARDS|Coronavirus,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,Umbilical Cord Lining Stem Cells (ULSC)|Placebo (carrier control)
322,323,NCT05035862,Asthma,Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma,Albuterol Sulfate|Interferon gamma-primed mesenchymal stromal cells (MSCs)|Prednisone
323,324,NCT04615429,Acute Respiratory Distress Syndrome|COVID-19 Pneumonia,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,Mesenchymal stromal cells|Placebo
324,325,NCT02484560,Duchenne Muscular Dystrophy,Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,Biological: Umbilical Cord Based Allogenic Mesenchymal Stem Cell
325,326,NCT03392311,Mesenchymal Stromal Cells|Psoriasis|Drug Effect|Drug Toxicity,Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis,Calcipotriol ointment|adipose-derived multipotent mesenchymal stem cells
326,327,NCT00515307,"Hypercholesterolemia, Familial",Bone Marrow Stem Cells as a Source of Allogenic Hepatocyte Transplantation in Homozygous Familial Hypercholesterolemia,Cellular transplantation
327,328,NCT04281797,Transplantation Infection|Kidney Transplant; Complications|Stem Cell Transplant Complications|Liver Transplant; Complications|Microbial Colonization,Intestinal Microbiome Dynamics in Solid Organ and Stem Cell Transplant Recipients,Intestinal microbiome new generation sequencing
328,329,NCT03484741,Type 1 Diabetes Mellitus,Mesenchymal Stem Cell Therapy for Type 1 Diabetes Mellitus Patients,MSC and PRP
329,330,NCT02582775,Epidermolysis Bullosa,MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs,Thymoglobulin|Cyclophosphamide|Fludarabine|Total Body Irradiation|Bone marrow infusion|Tacrolimus|Mycophenolate Mofetil|Donor mesenchymal stem cell infusions|Busulfan
330,331,NCT03943576,Knee Osteoarthritis,Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis,GXCPC1|HA
331,332,NCT05456243,Kidney Transplant,Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients,Low dose adipose tissue derived mesenchymal stromal cells (A-MSC)|High dose adipose tissue derived mesenchymal stromal cells (A-MSC)
332,333,NCT02635464,Chronic Ischemic Cardiomyopathy,Human Umbilical Cord-derived Mesenchymal Stem Cells With Injectable Collagen Scaffold Transplantation for Chronic Ischemic Cardiomyopathy,hUC-MSCs+Injectable collagen scaffold+CABG|hUC-MSCs+CABG|CABG
333,334,NCT03529877,Recessive Dystrophic Epidermolysis Bullosa,Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa,allo-APZ2-EB
334,335,NCT05407766,Rectal Fistula,Mesenchymal Stem Cells (MSCs) for Perianal Fistula,OSSM-001|Placebo
335,336,NCT03672825,Cartilage Defect,REcycled CartiLage Auto/Allo IMplantation,REcycled CartiLage Auto/Allo IMplantation
336,337,NCT04276987,Coronavirus,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,MSCs-derived exosomes
337,338,NCT04501341,T2D,BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients,"Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC|Intravenous Infusion of UC-MSC"
338,339,NCT00136903,Graft Vs Host Disease,Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD),Prochymal® - 2 Million cells/kg|Prochymal®- 8 Million cells/kg|Methylprednisolone|Prednisone|Cyclosporine|Tacrolimus|Mycophenolate Mofetil
339,340,NCT03684122,Parkinson Disease,Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD).,Injection of Umbilical cord derived MSCs
340,341,NCT02962661,Cardiomyopathy|Heart Failure|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm,Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines,Best Practice|Laboratory Biomarker Analysis|Mesenchymal Stem Cell Transplantation|Mesenchymal Stem Cell Transplantation
341,342,NCT01686139,Type I Diabetes Mellitus With Ulcer|Type II Diabetes Mellitus With Ulcer,Safety Study of Stem Cells Treatment in Diabetic Foot Ulcers,ABMD-MSC
342,343,NCT01844063,Liver Failure,Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure,Conventional plus BM-MSC treatment|Conventional plus UC-MSC treatment|Conventional treatment
343,344,NCT03726255,Perianal Fistula,Stem Cell Therapy: a Compassionate Use Program in Perianal Fistula,Mesenchymal Stem Cell injection
344,345,NCT04377334,ARDS|COVID-19,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),MSC
345,346,NCT05126563,Post COVID-19 Syndrome,Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome,HB-adMSCs (allogeneic)|Placebo
346,347,NCT02917291,Acute Traumatic Spinal Cord Injury,Safety and Preliminary Efficacy of FAB117-HC in Patients With Acute Traumatic Spinal Cord Injury,FAB117-HC|Control group|FAB117-HC
347,348,NCT01061099,Osteogenesis Imperfecta Type II|Osteogenesis Imperfecta Type III,Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta,Mesenchymal Stromal Cells
348,349,NCT02561767,Kidney Transplantation|Acute Kidney Tubular Necrosis,Effect of BM-MSCs in DCD Kidney Transplantation,bone marrow-derived mesenchymal stem cells|Saline|Induction therapy (ATG or Basiliximab)|Maintenance therapy (Low-dose CNI + MPA + steroids)
349,350,NCT04544215,Drug-resistant,A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection,Dosage 1 of MPCs-derived exosomes|Dosage 2 of MPCs-derived exosomes|No MPCs-derived exosomes
350,351,NCT03173638,Non Arteritic Ischemic Optic Neuropathy,Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy,intravitreal injection of MSV
351,352,NCT03920397,Type 1 Diabetes Mellitus,Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus,Infusion of adipose tissue-derived stem/stromal cells and oral Cholecalciferol supplementation
352,353,NCT01033552,Epidermolysis Bullosa,"Biochemical Correction of Severe EB by Allo HSCT and ""Off-the-shelf"" MSCs",Cyclophosphamide|Fludarabine|Anti-thymocyte globulin|Cyclosporine A|Mycophenolate mofetil|Mesenchymal stem cell transplantation|Total body irradiation|Bone marrow or umbilical cord blood (UCG) stem cell transplantation
353,354,NCT01941394,Graft-versus-host Disease|Relapse,Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation,Mesenchymal stem cells
354,355,NCT04434768,Acute Stroke,Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Ischemic Stroke,UMSC01
355,356,NCT02083731,"Stem Cell Transplantation, Hematopoietic|CMV Infection|Hematological Diseases",MSC for Treatment of CMV Infection,MSCs
356,357,NCT01045382,"Leukemia, Myeloid, Acute|Leukemia, Lymphoblastic, Acute|Leukemia, Myelocytic, Chronic|Myeloproliferative Disorders|Myelodysplastic Syndromes|Multiple Myeloma|Leukemia, Lymphocytic, Chronic|Hodgkin's Disease|Lymphoma, Non-Hodgkin",MSC and HSC Coinfusion in Mismatched Minitransplants,Mesenchymal stem cells|Isotonic solution
357,358,NCT01443689,Burns,Allogenic Stem Cell Therapy in Patients With Acute Burn,human umbilical cord mesenchymal stem cells|human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells|Conventional therapy
358,359,NCT05345418,Sexual Dysfunction Male,Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency,Umbilical Cord-Derived Mesenchymal Stem Cell for Male Patients with Sexual Deficiency
359,360,NCT04661644,Critical Limb Ischemia,Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients With Critical Limb Ischemia,Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^7 cells/1 mL/vial)|Clusters of adipose-derived mesenchymal stem cells (Dose: 1 x 10^8 cells/1 mL/vial)
360,361,NCT03943940,Type 2 Diabetes Mellitus,BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients,BM-MNC and UC-MSC|Control
361,362,NCT04499105,Degenerative Disc Disease|Low Back Pain|Disc Degeneration,Effectiveness and Safety of Mesenchymal Stem Cell (MSC) Implantation on Degenerative Discus Disease Patients,"Mesenchymal Stem Cell + NaCl 0,9% 2ml"
362,363,NCT02270307,Leukemia|Multiple Myeloma,MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis,Cyclophosphamide|Mesenchymal stromal cells
363,364,NCT00883870,Critical Limb Ischemia,Mesenchymal Stem Cells in Critical Limb Ischemia,mesenchymal stem cells|Plasmalyte A
364,365,NCT04445220,COVID-19|Acute Kidney Injury|Sepsis,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,SBI-101
365,366,NCT02481440,Spinal Cord Injuries,Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI,human umbilical cord mesenchymal stem cells (hUC-MSCs)
366,367,NCT02034188,Multiple Sclerosis,Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis,Umbilical cord mesenchymal stem cells
367,368,NCT03964922,"Relapse Leukemia|Allogeneic Stem Cell Transplantation|Immune Evasion, Tumor",Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation,blood sample|bone marrow sample
368,369,NCT01985464,Rheumatoid Arthritis,Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis,Umbilical cord mesenchymal stem cells
369,370,NCT04457609,COVID|Pulmonary Infection|Sars-CoV2,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,Oseltamivir|Azithromycin|Umbilical Cord Mesenchymal Stem Cells
370,371,NCT04629833,Steroid-refractory Acute Graft-versus-host Disease,Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy,MC0518|BAT
371,372,NCT04903327,Covid19,Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress,COVI-MSC|Placebo
372,373,NCT05204329,Mesenchymal Stromal Cells|Cornea|Corneal Defect|Corneal Epithelium Defect,Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease,MSC Secretome Eye Drops
373,374,NCT02237846,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis,Human umbilical cord tissue-derived mesenchymal stem cells
374,375,NCT02387723,Heart Failure,CSCC_ASC Therapy in Patients With Severe Heart Failure,Allogeneic adipose derived stem cells (CSCC_ASC)
375,376,NCT03015623,Acute Kidney Injury,A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy,SBI-101|Sham
376,377,NCT04919135,Frailty,Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty,Umbilical Cord Mesenchymal Stem Cells transplantation|standard frailty treatment and supplementary medication
377,378,NCT00705120,Osteogenesis Imperfecta,Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation,"Bone Marrow Cell Transplantation|Irradiation, Total Body|Cyclophosphamide|Cyclosporin|Mesenchymal Stem Cell Transplantation|Busulfan"
378,379,NCT05549609,Venous Leg Ulcer,A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers,XSTEM-VLU|Vehicle
379,380,NCT04776538,Xerostomia Following Radiotherapy,Safety and Efficacy of Mesenchymal Stem Cell for Radiation-induced Hyposalivation and Xerostomia in Previous Head and Neck Cancer Patients,Stem cells|Placebo
380,381,NCT03370874,Diabetic Foot Ulcer,Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.,ALLO-ASC-DFU|Vehicle sheet
381,382,NCT00951210,Peripheral Artery Disease|Peripheral Vascular Disease|Critical Limb Ischemia,Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI),PLX-PAD
382,383,NCT03754465,Diabetic Foot Ulcer,Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers,ALLO-ASC-DFU|Hydrogel SHEET(Vehicle control)
383,384,NCT01041001,Cartilage Injury|Osteoarthritis,Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury,Cartistem|Microfracture treatment
384,385,NCT03169231,Aging Frailty,Phase IIb Trial to Evaluate Longeveron Mesenchymal Stem Cells to Treat Aging Frailty,Longeveron Mesenchymal Stem Cells (LMSCs)|Placebo
385,386,NCT02409940,Renal Transplant Rejection,To Elucidate the Effect of Mesenchymal Stem Cells on the T Cell Repertoire of the Kidney Transplant Patients,Mesenchymal Stem Cells
386,387,NCT03505034,Spinal Cord Injuries,Intrathecal Transplantation of UC-MSC in Patients With Late Stage of Chronic Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells
387,388,NCT04061746,"Diabetes Mellitus, Type 1",Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells,Mesenchymal Stem Cells (MSCs)|Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)
388,389,NCT02055625,Graft -Versus-host-disease,Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease,Mesenchymal stromal cells
389,390,NCT03183726,Diabetic Foot Ulcer,A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial,ALLO-ASC-DFU
390,391,NCT01849887,Ischemic Stroke,Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke,bone marrow-derived mesenchymal stem cells|Placebo
391,392,NCT03183661,Crohn Disease,A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial,ALLO-ASC-CD
392,393,NCT01539902,Lupus Nephritis,Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis,Human Umbilical Cord derived MSCs|Cyclophosphamide
393,394,NCT03847844,Acute-graft-versus-host Disease,UCMSCs as Front-line Approach of Treatment for Patients With aGVHD,Umbilical cord derived mesenchymal stem cell|Placebo
394,395,NCT03521336,Spinal Cord Injury,Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells|Placebo
395,396,NCT03521323,Spinal Cord Injuries,Intrathecal Transplantation of UC-MSC in Patients With Early Stage of Chronic Spinal Cord Injury,Umbilical Cord Mesenchymal Stem Cells|Placebos
396,397,NCT01392105,Acute Myocardial Infarction,Safety and Efficacy of Intracoronary Adult Human Mesenchymal Stem Cells After Acute Myocardial Infarction,Mesenchymal stem cell|Control group
397,398,NCT00919958,Peripheral Artery Disease|Peripheral Vascular Disease|Critical Limb Ischemia,Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia,PLX-PAD IM injection
398,399,NCT03810521,"Osteoarthritis, Knee",Dose-escalation of Cellistem-OA in Patients With Knee Osteoarthritis,umbilical cord derived-mesenchymal stromal cells
399,400,NCT04971980,Rheumatoid Arthritis,Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis,hUC-MSC infusion (BC-U001)
400,401,NCT00827398,Graft-versus-host-disease,Treatment of Steroid Resistant GVHD by Infusion MSC,MSC (hPPL)
401,402,NCT01663116,Rheumatoid Arthritis Aggravated,"Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients",Stem cells|Placebo
402,403,NCT02260375,Liver Transplant Rejection,MSC Therapy in Liver Transplantation,Mesenchymal Stromal Cells
403,404,NCT04953663,Stroke,Clinical Plan of Ischemic Stroke,it-hMSC
404,405,NCT01541579,Crohn's Disease,Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease,Cx601|Saline solution
405,406,NCT05075811,"Pouch, Ileal|Fistula",Study of Ossium Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in the Setting of Crohn's Disease,Ossium vBM-MSC|Placebo
406,407,NCT04093336,"Infarction, Middle Cerebral Artery|Infarction, Anterior Cerebral Artery|Cerebral Infarction|Stroke, Ischemic|Acute Stroke|Brain Infarction|Infarction, PCA|Infarction, Posterior Circulation, Brain",Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients,human umbilical cord mesenchymal stem cells|Placebo|standardized treatment
407,408,NCT02648386,Rectal Cancer|Erectile Dysfunction,Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery,Laparoscopic surgery|NeuroRegen scaffold transplantation|NeuroRegen scaffold/BMMCs transplantation|NeuroRegen scaffold/HUC-MSCs transplantation
408,409,NCT05329662,Sexual Dysfunction Female,Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female,Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency
409,410,NCT04435249,Bronchopleural Fistula,ENgineered Tissue Repair of BronchopleUral fiSTula,BPF-001
410,411,NCT02410239,Cerebral Adrenoleukodystrophy,MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD),Mesenchymal Stem Cells
411,412,NCT03219801,Systemic Lupus Erythematosus,Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus,mesenchymal stem cells
412,413,NCT02982915,Aging Frailty,Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty,Longeveron Mesenchymal Stem Cells (LMSCs)|Fluzone High Dose Vaccine
413,414,NCT03003364,"Spinal Cord Injury, Chronic",Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury,XCEL-UMC-BETA|Placebo
414,415,NCT00557635,Tibia or Femur Pseudo-arthrosis,Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow,Chirurgical procedure
415,416,NCT04961658,Septic Shock,Advanced Mesenchymal Enhanced Cell THerapY for SepTic Patients,GEM00220
416,417,NCT00988338,"Tibiotalar Arthrodesis|Subtalar Arthrodesis|Calcaneocuboid Arthrodesis|Talonavicular Arthrodesis|Double Arthrodesis (i.e. Calcaneocuboid and Talonavicular)|Triple Arthrodesis (i.e. Subtalar, Calcaneocuboid, and Talonavicular)",Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion,Trinity Evolution
417,418,NCT01602328,Acute Kidney Injury,A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects,AC607|Vehicle Only
418,419,NCT02359929,Graft Versus Host Disease|Acute Graft Versus Host Disease|Chronic Graft Versus Host Disease,BMT Autologous MSCs for GvHD,Autologous mesenchymal stromal cells (MSCs)
419,420,NCT03267784,Diabetic Neuropathic Ulcer,"Allogeneic ABCB5-positive Stem Cells for Treatment of DFU ""Malum Perforans""",allo-APZ2-DFU
420,421,NCT02336230,Grade B aGVHD|Grade C aGVHD|Grade D aGVHD,"A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)",remestemcel-L
421,422,NCT02483364,Pseudoarthrosis,A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure),HC-SVT-1001(initial protocol); HC-SVT-1002 (protocol amendment)
422,423,NCT05210309,"Safety|Efficacy, Self",National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study),Stem Cell Therapy
423,424,NCT04896853,COVID-19 Acute Respiratory Distress Syndrome,Treatment of Respiratory Complications Associated With COVID-19 Infection Using ProTrans®,ProTrans®
424,425,NCT03631589,Steroid-resistant Severe aGVHD,MSC for Severe aGVHD,MSCs
425,426,NCT02706132,Liver Transplantation,Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation,Mesenchymal Stem Cells(MSCs)
426,427,NCT04194671,Acute Kidney Injury|Mesenchymal Stem Cells,Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury,Mesenchymal stem cells|Saline
427,428,NCT03166865,Osteoarthritis of the Knee,Clinical Study of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for Treatment of Knee Osteoarthritis,Umbilical-cord mesenchymal stromal cells (UC-MSCs)|Hyaluronic acid
428,429,NCT02381366,Bronchopulmonary Dysplasia,Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study,Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
429,430,NCT05443464,"GVHD,Acute",Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD),OSSM-001
430,431,NCT01489267,Hereditary Cerebellar Ataxia.,A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation,stem cell transplantation
431,432,NCT02854579,Hypoxic-Ischemic Encephalopathy,Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy,neural progenitor cell|Paracrine factors|progenitor cell and paracrine factors
432,433,NCT01739777,Dilated Cardiomyopathy,Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy,ucMSC|Controls
433,434,NCT04011059,Cardiovascular Diseases|Heart Failure|Coronary Artery Disease|Mesenchymal Stem Cell Transplantation|Regenerative Medicine,Randomized Study of Coronary Revascularization Surgery With Injection of WJ-MSCs and Placement of an Epicardial Extracellular Matrix,Wharton's jelly-derived mesenchymal cells
434,435,NCT02379442,Graft-Versus-Host Disease,Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids,MSC
435,436,NCT01754454,Acute GVH Disease,Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease,Human Umbilical Cord Derived MSC
436,437,NCT02644447,Premature Ovarian Failure,Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF,HUC-MSCs Transplantation|HUC-MSCs with Injectable Collagen Scaffold Transplantation
437,438,NCT05292625,Ischemic Stroke,Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke,UC-MSC infusion via intravenous route|UC-MSC infusion via intrathecal route|standard stroke treatment and rehabilitation therapy
438,439,NCT04416139,Covid 19,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,Infusion IV of Mesenchymal Stem cells
439,440,NCT01558908,Peripheral Vascular Diseases,Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia,Administration of ERC
440,441,NCT05338099,Duchenne Muscular Dystrophy,Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD),EN001|EN001
441,442,NCT05333406,"Charcot-Marie-Tooth Disease, Type IA",Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A,EN001|EN001
442,443,NCT03525418,HLHS,Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS),Longeveron Mesenchymal Stem Cells
443,444,NCT02037204,Foreign-Body Reaction|Inflammation|Effusion (L) Knee|Knee Pain Swelling,IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.,Cartilage repair surgery
444,445,NCT03828344,Rheumatoid Arthritis,Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis,hUC-MSC suspension|Placebo
445,446,NCT04482699,Severe COVID-19 Disease,RAPA-501-Allo Therapy of COVID-19-ARDS,RAPA-501-Allo off-the-shelf Therapy of COVID-19|Placebo
446,447,NCT05331872,Liver Cirrhosis,Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis,Human umbilical cord-derived mesenchymal stem cell infusion
447,448,NCT05497401,Covid-related Pneumonia,A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With COVID-related Pneumonia,MesenCure|Placebo
448,449,NCT04520945,"Osteoarthritis, Knee",Phase 2B Clinical Study of Chondrogen for Treatment of Knee Osteoarthritis,Chondrogen|Placebo
449,450,NCT04234412,"Osteoarthritis, Knee",Treatment of Osteoarthritic Knee With High Tibial Osteotomy and Implantation of Allogenic Human Umbilical Cord Blood-derived Stem Cells.,umbilical cord blood stem cell implantation for osteoarthritis treatment
450,451,NCT03629015,Stem Cells|Adult Stem Cells|Acute Liver Failure|Acute-On-Chronic Liver Failure|Steminent,Safety Study of Stemchymal® in Acute Liver Failure,Stemchymal®
451,452,NCT02580695,Osteoarthritis,A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis,umbilical-cord mesenchymal stromal cells|Hyaluronic Acid
452,453,NCT01460901,Neuroblastoma,"Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma",GD2 CAR modified Tri-virus specific cytotoxic t-cells
453,454,NCT05531266,aGVHD,Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease,hUC-MSCs|glucocorticoids
454,455,NCT03896568,IDH1 wt Allele|Recurrent Anaplastic Astrocytoma|Recurrent Glioblastoma|Recurrent Gliosarcoma|Recurrent Malignant Glioma,MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma,Oncolytic Adenovirus Ad5-DNX-2401|Therapeutic Conventional Surgery
455,456,NCT03257098,Skin Ulcer Venous Stasis Chronic,Allogeneic ABCB5-positive Stem Cells for Treatment of CVU,allo-APZ2-CVU
456,457,NCT03378063,Bronchopulmonary Dysplasia,Stem Cells for Bronchopulmonary Dysplasia,transplantation of mesenchymal stem cell|no transplantation of mesenchymal stem cell
457,458,NCT04089579,Autism|Autism Spectrum Disorder,hCT-MSC in Children With Autism Spectrum Disorder,Cord Tissue Mesenchymal Stromal Cells|Placebo Infusion
458,459,NCT02407470,Severe Aplastic Anemia,Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia,Rabbit antithymoglobulin (ATG)|Adipose derived mesenchymal stem cells ( AD-MSCs)|AD-MSC transdifferentiated HSCs (AD-HSCs)
459,460,NCT04313647,Healthy,A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers,1X level of MSCs-Exo|2X level of MSCs-Exo|4X level of MSCs-Exo|6X level of MSCs-Exo|8X level of MSCs-Exo
460,461,NCT02543073,"Lung Diseases, Interstitial|Hematopoietic Stem Cell Transplantation|Bronchiolitis Obliterans",MSC for Treatment of Interstitial Lung Disease After Allo-HSCT,MSCs|AZM|Glucocorticoid
461,462,NCT04738981,Graft Vs Host Disease,Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT,UC-MSC|Anti-CD25 mAb
462,463,NCT02580617,Crohn's Disease,A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease,ALLO-ASC
463,464,NCT04399889,COVID|Corona Virus Infection|COVID19,hCT-MSCs for COVID19 ARDS,Human cord tissue mesenchymal stromal cells (hCT-MSC) manufactured by Duke University.|Placebo
